Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine

Benzer Materyaller

• Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
  Yazar:: Findlow, Jamie, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
  Yazar:: Findlow, Jamie, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Combined Administration of Meningococcal Serogroup B Outer Membrane Vesicle Vaccine and Conjugated Serogroup C Vaccine Indicated for Prevention of Meningococcal Disease Is Safe and Immunogenic
  Yazar:: Aaberge, Ingeborg S., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines
  Yazar:: Sandbu, Synne, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
  Yazar:: Holst, Johan, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)